Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy-Reference-Cited by-同舟云学术

Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy

Published:2018-11-12 Issue:7 Volume:62 Page:3171-3183
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Luan Yepeng¹,Li Jerry,Bernatchez Jean A.,Li Rongshi¹²^ORCID

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao 266071, Shandong Province, China

2. UNMC Center for Drug Discovery, Department of Pharmaceutical Sciences, College of Pharmacy, Fred and Pamela Buffett Cancer Center, and Center for Staphylococcal Research, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

Funder

University of Nebraska Medical Center

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00189

Reference96 articles.

1. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

2. The role of histone deacetylases (HDACs) in human cancer

3. Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy

4. Histone Deacetylase Inhibitors: From Bench to Clinic

5. Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and antitumor activities of phthalazinone derivatives as PARP-1 inhibitors and PARP-1/HDAC-1 inhibitors;Bioorganic Chemistry;2024-10

2. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment;European Journal of Medicinal Chemistry;2024-09

3. Targeted small molecule therapy and inhibitors for lymphoma;Future Medicinal Chemistry;2024-07-17

4. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer;Journal of Experimental & Clinical Cancer Research;2024-07-11

5. Molecular hybridization: a powerful tool for multitarget drug discovery;Expert Opinion on Drug Discovery;2024-03-08